Parametric Portfolio Associates’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-27,975
| Closed | -$69K | – | 3727 |
|
|
2021
Q4 | $69K | Sell |
27,975
-128
| -0.5% | -$316 | ﹤0.01% | 3586 |
|
|
2021
Q3 | $71K | Buy |
28,103
+4,874
| +21% | +$12.3K | ﹤0.01% | 3558 |
|
|
2021
Q2 | $66K | Buy |
23,229
+1,165
| +5% | +$3.31K | ﹤0.01% | 3515 |
|
|
2021
Q1 | $52K | Buy |
+22,064
| New | +$52K | ﹤0.01% | 4021 |
|
|
2019
Q1 | – | Sell |
-16,696
| Closed | -$15K | – | 3950 |
|
|
2018
Q4 | $15K | Sell |
16,696
-21,567
| -56% | -$19.4K | ﹤0.01% | 3890 |
|
|
2018
Q3 | $79K | Sell |
38,263
-4,481
| -10% | -$9.25K | ﹤0.01% | 3871 |
|
|
2018
Q2 | $77K | Buy |
42,744
+1,499
| +4% | +$2.7K | ﹤0.01% | 3825 |
|
|
2018
Q1 | $97K | Buy |
41,245
+25,106
| +156% | +$59K | ﹤0.01% | 3862 |
|
|
2017
Q4 | $30K | Buy |
16,139
+1,464
| +10% | +$2.72K | ﹤0.01% | 3885 |
|
|
2017
Q3 | $36K | Buy |
14,675
+1,102
| +8% | +$2.7K | ﹤0.01% | 4000 |
|
|
2017
Q2 | $37K | Buy |
+13,573
| New | +$37K | ﹤0.01% | 3971 |
|